Glenview Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
Other funds holding AGIO
Glenview Capital Management's AGIO Position: Q3 2026 in Review
Glenview Capital Management opened a new position in Agios Pharmaceuticals (AGIO) in Q3 2026: 459,792 shares worth $15.3M. The stake represents 0.25% of the portfolio and ranks #47 among its holdings.
243 funds tracked by Wall St. Rank hold AGIO as of Q3 2026.
- Glenview Capital Management held 459,792 shares of Agios Pharmaceuticals worth $15.3M as of Q3 2026.
- Agios Pharmaceuticals was a new Glenview Capital Management position in Q3 2026.
- Agios Pharmaceuticals made up 0.25% of Glenview Capital Management's portfolio in Q3 2026, its #47 holding.
- 243 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2026.
Based on Glenview Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.